Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-20

Clinical Trial Update: Progesterone in Threatened Abortion [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating progesterone for threatened abortion in the first trimester has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: IBSA Institut Biochimique SA | Conditions: Threatened Abortion in First Trimester | Phase 3 | Status: TERMINATED